While SELENOP expression was still lower in MSS cancers than in differentiated epithelial cells, we hypothesize that SELENOP upregulation throughout progression to malignancy fortifies tumor-promotive WNT signaling activity. This evidence concerns the gene SELENOP and Marinesco-Sjogren syndrome.